75 reports

  • 4.1 CATALYST

Resulting from a complex interaction of biomechanical, biochemical, and genetic factors, OA develops slowly and is characterized by the degradation of the affected joint' s cartilage and bone hypertrophy.

  • Orthopedics
  • Anika Therapeutics, Inc.
  • Ferring International Center S.A.
  • Sanofi S.A.
  • Seikagaku Corporation
  • 4.1 CATALYST

Resulting from a complex interaction of biomechanical, biochemical, and genetic factors, OA develops slowly and is characterized by the degradation of the affected joint' s cartilage and bone hypertrophy.

  • Orthopedics
  • North America
  • Anika Therapeutics, Inc.
  • Sanofi S.A.
  • Seikagaku Corporation
  • 1.4 Hip Surgery

Pain of the hip may be the result of numerous causes including nervous, osteoarthritic, infectious, trauma-related, and genetic ones.

  • Orthopedics
  • United States
  • Johnson & Johnson
  • Smith & Nephew Plc
  • Stryker Corporation

ISPOR CONNECTIONS; ##(##): ##-##.

  • Orthopedics
  • World
  • Market Size
  • Baumer
  • DePuy Synthes, Inc.
  • GLOBAL ORTHOBIOLOGICS MARKET BY BONE MORPHOGENETIC PROTEINS 2015-2020 ($ MILLIONS)
  • GLOBAL ORTHOBIOLOGICS MARKET BY ALLOGRAFTS

These proteins, produced through genetic engineering, can help in bone healing.

  • Orthopedics
  • DePuy Synthes, Inc.
  • Medtronic, Inc.
  • Sanofi S.A.
  • Stryker Corporation
  • 4.1 CATALYST

term=NCT##& rank=##.

  • Orthopedics
  • Therapy
  • Anika Therapeutics, Inc.
  • Ferring International Center S.A.
  • Sanofi S.A.

All of these products have the ability to help fracture re-growth using genetic engineering.

  • Orthopedics
  • Arthrex, Inc.
  • CONMED Corporation
  • DePuy Mitek, Inc.
  • DePuy Synthes, Inc.
  • 4.1 CATALYST

Resulting from a complex interaction of biomechanical, biochemical, and genetic factors, OA develops slowly and is characterized by the degradation of the affected joint' s cartilage and bone hypertrophy.

  • Medical Device
  • Orthopedics
  • Ferring International Center S.A.
  • Sanofi S.A.
  • Seikagaku Corporation
  • 7.2 SEGMENTATION - BY GEOGRAPHY

Back pain is common in adolescents due to multiple reasons, including physical, behavioural, genetic, and psychosocial factors.

  • Orthopedics
  • United States
  • Market Size
  • K2M Group Holdings, Inc.
  • NuVasive, Inc.
  • 4.1 CATALYST

Resulting from a complex interaction of biomechanical, biochemical, and genetic factors, OA develops slowly and is characterized by the degradation of the affected joint' s cartilage and bone hypertrophy.

  • Orthopedics
  • Forecast
  • Anika Therapeutics, Inc.
  • Ferring International Center S.A.
  • Sanofi S.A.
  • MARKET DRIVERS

These proteins, which are produced through genetic engineering, help with bone healing.

  • Orthopedics
  • Japan
  • DePuy Synthes, Inc.
  • Medtronic, Inc.
  • Smith & Nephew Plc
  • 3.2.1 Global Knee Implant Market by Value

Growth in the market was primarily driven by increasing incidence of roadside accidents, occurrence of arthritis among aging population, genetic inheritance factors, etc.

  • Orthopedics
  • United States
  • DePuy Orthopaedics, Inc.
  • Johnson & Johnson
  • Smith & Nephew Plc
  • 4.1 CATALYST

Resulting from a complex interaction of biomechanical, biochemical, and genetic factors, OA develops slowly and is characterized by the degradation of the affected joint' s cartilage and bone hypertrophy.

  • Orthopedics
  • South America
  • Anika Therapeutics, Inc.
  • Ferring International Center S.A.
  • Sanofi S.A.

It is a tissue-engineered product, which received orphan drug designation in Europe and the US for osteogenesis imperfecta, a genetic disorder that leads to bone fragility.

  • Orthopedics
  • World
  • DePuy Synthes, Inc.
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • KEY MARKET HIGHLIGHTS

It is a tissue-engineered product, which received orphan drug designation in Europe and the US for osteogenesis imperfecta, a genetic disorder, which leads to bone fragility.

  • Orthopedics
  • DePuy Synthes, Inc.
  • Stryker Corporation
  • Wright Medical Group
  • Zimmer Biomet Holdings, Inc.

Others ##.

  • Orthopedics
  • World
  • Demand
  • Forecast
  • Market Size

One unit refers to one pack of five Hyaluronic acid injections.

  • Orthopedics
  • Japan
  • CollPlant
  • Medtronic, Inc.
  • Seikagaku Corporation

Only Denmark has more, at ##. ## scanners per ## m population.

  • Healthcare
  • Hospital
  • Orthopedics
  • Netherlands
  • TforG Group

Only Denmark has more, at ##. ## scanners per ## m population.

  • Healthcare
  • Hospital
  • Orthopedics
  • Netherlands
  • TforG Group

Subscription to one of these five funds is mandatory.

  • Healthcare
  • Hospital
  • Orthopedics
  • Belgium
  • TforG Group

Subscription to one of these five funds is mandatory.

  • Healthcare
  • Hospital
  • Orthopedics
  • Belgium
  • TforG Group

Allograft bone chips are the transplanted bones, sourced from a genetically non-identical living or dead member of the same species.

  • Orthopedics
  • China
  • CollPlant
  • Medtronic, Inc.
  • Seikagaku Corporation

Allograft bone chips are the transplanted bones, sourced from a genetically non-identical living or dead member of the same species.

  • Orthopedics
  • Market Size
  • Arthrex, Inc.
  • Baxter International Inc.
  • Bioventus LLC

Allograft bone chips are the transplanted bones, sourced from a genetically non-identical living or dead member of the same species.

  • Orthopedics
  • Italy
  • Anika Therapeutics, Inc.
  • Arthrex, Inc.
  • Baxter International Inc.

Allograft bone chips are the transplanted bones, sourced from a genetically non-identical living or dead member of the same species.

  • Orthopedics
  • United Kingdom
  • Anika Therapeutics, Inc.
  • CollPlant
  • Medtronic, Inc.

Allograft bone chips are the transplanted bones, sourced from a genetically non-identical living or dead member of the same species.

  • Orthopedics
  • India
  • Anika Therapeutics, Inc.
  • Arthrex, Inc.
  • Baxter International Inc.

Allograft bone chips are the transplanted bones, sourced from a genetically non-identical living or dead member of the same species.

  • Orthopedics
  • Spain
  • Anika Therapeutics, Inc.
  • Baxter International Inc.
  • Biomet, Inc.
  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT

A nonsense mutation is an alteration in the genetic code that prematurely halts the synthesis of an essential protein.

  • Orthopedics
  • Australasia
  • Australia
  • Oceania
  • Market Size

Advances in genetic engineering and orthopedic medicine have allowed the replacement of traditional orthopedic biomaterials in spine surgeries.

  • Orthopedics
  • Medtronic, Inc.
  • NuVasive, Inc.
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.

Allograft bone chips are the transplanted bones, sourced from a genetically non-identical living or dead member of the same species.

  • Orthopedics
  • East Asia
  • Market Size
  • Arthrex, Inc.
  • Bioventus LLC